Down-regulation of central glucocorticoid receptor expression using antisense oligonucleotide technology
Endogenous glucocorticoids and serotonin have been implicated in the pathophysiology of depression, anxiety and schizophrenia. This thesis investigates the potential of downregulating expression of central Type II glucocorticoid receptors (GR) both in vitro and in vivo, with empirically-designed ant...
Main Author: | Islam, Aminul |
---|---|
Published: |
Aston University
2000
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.341351 |
Similar Items
-
Evaluation of biodegradable polymer microspheres and an anionic dendrimer for the potential delivery of antisense oligonucleotides
by: Hussain, Majad
Published: (2002) -
The role of antisense Bcl-2 oligonucleotides in bladder cancer
by: Duggan, Brian J.
Published: (2000) -
Second messenger pathways in the action of cachectic factors
by: Islam-Ali, Bilkis S.
Published: (2001) -
Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth
by: Jun Chen, et al.
Published: (2000-05-01) -
Using Desferoxamine to Enhance Transferrin Receptor-Targeted Antisense Oligonucleotides Delivery
by: Jyun-Tsang He, et al.
Published: (2010)